New York City-based Icahn School of Medicine at Mount Sinai has launched New York's first ophthalmology-focused artificial intelligence research center, the Center for Ophthalmic Artificial Intelligence and Human Health.
In partnership with the Windreich Department of Artificial Intelligence and Human Health at Icahn Mount Sinai, researchers will advance innovation in AI-based diagnostic ophthalmology care so that AI can be incorporated into physician education, research and clinical care.
James Tsai, MD, will be the center's inaugural director, leading with two co-directors Louis Pasquale, MD, and Alon Harris, PhD, according to a July 5 press release.
The center will begin by researching and implementing AI across Mount Sinai's tele-retina, ophthalmology tele-consult and eye stroke programs.
The center will develop validated AI models that can be used to interpret digital retina images and calculate patient risk of adverse health events.